Thomas W. K.
- Country
- Germany
- Department
- Hematology - Oncology - Palliative medicine
Research Overview
Data & Insights
Has run more than one trial at 0 of 140 partner sites.
Specializations
Oncology Research
This investigator specializes in studying treatments for colon and rectal cancers, with particular emphasis on stage II disease management. Their research explores innovative approaches to adjuvant therapy decision-making using circulating tumor DNA (ctDNA) analysis.
- Colorectal Cancer Treatment
- Biomarker-Guided Therapy
- Disease-Free Survival Assessment
The investigator's work contributes to personalizing treatment strategies in early-stage colorectal cancer.
Hematologic Oncology
The investigator focuses on advancing treatment protocols for mantle cell lymphoma, investigating combination therapies including rituximab and ibrutinib. Their research encompasses both traditional and novel therapeutic approaches in lymphoma treatment.
- Lymphoma Treatment Protocols
- Autologous Stem Cell Transplantation
- Maintenance Therapy Strategies
The research aims to establish optimal treatment sequences for patients with generalized mantle cell lymphoma.
Clinical Innovation
This investigator develops comparative treatment strategies in oncology, evaluating both conventional and emerging therapeutic approaches. Their work includes assessment of failure-free survival and treatment optimization.
- Treatment Protocol Development
- Therapeutic Response Assessment
- Clinical Outcomes Analysis
The research focuses on establishing evidence-based standards for complex oncological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.